255 related articles for article (PubMed ID: 24375628)
1. ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis.
Romagnoli M; Mineva ND; Polmear M; Conrad C; Srinivasan S; Loussouarn D; Barillé-Nion S; Georgakoudi I; Dagg Á; McDermott EW; Duffy MJ; McGowan PM; Schlomann U; Parsons M; Bartsch JW; Sonenshein GE
EMBO Mol Med; 2014 Feb; 6(2):278-94. PubMed ID: 24375628
[TBL] [Abstract][Full Text] [Related]
2. miR-720 is a downstream target of an ADAM8-induced ERK signaling cascade that promotes the migratory and invasive phenotype of triple-negative breast cancer cells.
Das SG; Romagnoli M; Mineva ND; Barillé-Nion S; Jézéquel P; Campone M; Sonenshein GE
Breast Cancer Res; 2016 Apr; 18(1):40. PubMed ID: 27039296
[TBL] [Abstract][Full Text] [Related]
3. ADAM8 expression in breast cancer derived brain metastases: Functional implications on MMP-9 expression and transendothelial migration in breast cancer cells.
Conrad C; Götte M; Schlomann U; Roessler M; Pagenstecher A; Anderson P; Preston J; Pruessmeyer J; Ludwig A; Li R; Kamm RD; Ritz R; Carl B; Nimsky C; Bartsch JW
Int J Cancer; 2018 Feb; 142(4):779-791. PubMed ID: 28986926
[TBL] [Abstract][Full Text] [Related]
4. ADAM8 in invasive cancers: links to tumor progression, metastasis, and chemoresistance.
Conrad C; Benzel J; Dorzweiler K; Cook L; Schlomann U; Zarbock A; Slater EP; Nimsky C; Bartsch JW
Clin Sci (Lond); 2019 Jan; 133(1):83-99. PubMed ID: 30635388
[TBL] [Abstract][Full Text] [Related]
5. ADAM8 as a drug target in pancreatic cancer.
Schlomann U; Koller G; Conrad C; Ferdous T; Golfi P; Garcia AM; Höfling S; Parsons M; Costa P; Soper R; Bossard M; Hagemann T; Roshani R; Sewald N; Ketchem RR; Moss ML; Rasmussen FH; Miller MA; Lauffenburger DA; Tuveson DA; Nimsky C; Bartsch JW
Nat Commun; 2015 Jan; 6():6175. PubMed ID: 25629724
[TBL] [Abstract][Full Text] [Related]
6. ADAM8 localizes to extravillous trophoblasts within the maternal-fetal interface and potentiates trophoblast cell line migration through a β1 integrin-mediated mechanism.
Le HT; Atif J; Mara DL; Castellana B; Treissman J; Baltayeva J; Beristain AG
Mol Hum Reprod; 2018 Oct; 24(10):495-509. PubMed ID: 30124911
[TBL] [Abstract][Full Text] [Related]
7. ADAM 8 as a novel target for doxorubicin delivery to TNBC cells using magnetic thermosensitive liposomes.
Alawak M; Abu Dayyih A; Mahmoud G; Tariq I; Duse L; Goergen N; Engelhardt K; Reddy Pinnapireddy S; Jedelská J; Awak M; König AM; Brüßler J; Bartsch JW; Bakowsky U
Eur J Pharm Biopharm; 2021 Jan; 158():390-400. PubMed ID: 33338603
[TBL] [Abstract][Full Text] [Related]
8. Expression levels of the metalloproteinase ADAM8 critically regulate proliferation, migration and malignant signalling events in hepatoma cells.
Awan T; Babendreyer A; Mahmood Alvi A; Düsterhöft S; Lambertz D; Bartsch JW; Liedtke C; Ludwig A
J Cell Mol Med; 2021 Feb; 25(4):1982-1999. PubMed ID: 33314720
[TBL] [Abstract][Full Text] [Related]
9. N-glycosylation regulates ADAM8 processing and activation.
Srinivasan S; Romagnoli M; Bohm A; Sonenshein GE
J Biol Chem; 2014 Nov; 289(48):33676-88. PubMed ID: 25336660
[TBL] [Abstract][Full Text] [Related]
10. Propofol affects the growth and metastasis of pancreatic cancer via ADAM8.
Yu X; Shi J; Wang X; Zhang F
Pharmacol Rep; 2020 Apr; 72(2):418-426. PubMed ID: 32048249
[TBL] [Abstract][Full Text] [Related]
11.
Li Y; Guo S; Zhao K; Conrad C; Driescher C; Rothbart V; Schlomann U; Guerreiro H; Bopp MH; König A; Carl B; Pagenstecher A; Nimsky C; Bartsch JW
Biol Chem; 2021 Jan; 402(2):195-206. PubMed ID: 33544472
[TBL] [Abstract][Full Text] [Related]
12. ADAM10 releases a soluble form of the GPNMB/Osteoactivin extracellular domain with angiogenic properties.
Rose AA; Annis MG; Dong Z; Pepin F; Hallett M; Park M; Siegel PM
PLoS One; 2010 Aug; 5(8):e12093. PubMed ID: 20711474
[TBL] [Abstract][Full Text] [Related]
13. ADAM8 expression is associated with increased invasiveness and reduced patient survival in pancreatic cancer.
Valkovskaya N; Kayed H; Felix K; Hartmann D; Giese NA; Osinsky SP; Friess H; Kleeff J
J Cell Mol Med; 2007; 11(5):1162-74. PubMed ID: 17979891
[TBL] [Abstract][Full Text] [Related]
14. Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer.
Xiang L; Gilkes DM; Chaturvedi P; Luo W; Hu H; Takano N; Liang H; Semenza GL
J Mol Med (Berl); 2014 Feb; 92(2):151-64. PubMed ID: 24248265
[TBL] [Abstract][Full Text] [Related]
15. Propofol inhibits pancreatic cancer progress under hypoxia via ADAM8.
Gao Y; Yu X; Zhang F; Dai J
J Hepatobiliary Pancreat Sci; 2019 Jun; 26(6):219-226. PubMed ID: 30945470
[TBL] [Abstract][Full Text] [Related]
16. The metalloproteinase ADAM8 promotes leukocyte recruitment in vitro and in acute lung inflammation.
Dreymueller D; Pruessmeyer J; Schumacher J; Fellendorf S; Hess FM; Seifert A; Babendreyer A; Bartsch JW; Ludwig A
Am J Physiol Lung Cell Mol Physiol; 2017 Sep; 313(3):L602-L614. PubMed ID: 28596294
[TBL] [Abstract][Full Text] [Related]
17. Propofol mediates pancreatic cancer cell activity through the repression of ADAM8 via SP1.
Gao Y; Zhou Y; Wang C; Sample KM; Yu X; Ben-David Y
Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34617574
[TBL] [Abstract][Full Text] [Related]
18. αB-crystallin: a novel regulator of breast cancer metastasis to the brain.
Malin D; Strekalova E; Petrovic V; Deal AM; Al Ahmad A; Adamo B; Miller CR; Ugolkov A; Livasy C; Fritchie K; Hamilton E; Blackwell K; Geradts J; Ewend M; Carey L; Shusta EV; Anders CK; Cryns VL
Clin Cancer Res; 2014 Jan; 20(1):56-67. PubMed ID: 24132917
[TBL] [Abstract][Full Text] [Related]
19. ADAM8 promotes chondrosarcoma cell migration and invasion by activating the NF-κB/MMP-13 signaling axis.
Liu Y; Li ZH; Zhang L; Lu SB
Anticancer Drugs; 2019 Aug; 30(7):e0790. PubMed ID: 31305294
[TBL] [Abstract][Full Text] [Related]
20. ADAM8 is a negative regulator of retinal neovascularization and of the growth of heterotopically injected tumor cells in mice.
Guaiquil VH; Swendeman S; Zhou W; Guaiquil P; Weskamp G; Bartsch JW; Blobel CP
J Mol Med (Berl); 2010 May; 88(5):497-505. PubMed ID: 20119708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
